BURLINGTON, N.C.--(BUSINESS WIRE)-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it is dedicating the first hour ...
Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a global life sciences company, is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers ...
BURLINGTON, N.C., March 31, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first ...
GlobalData on MSN
Labcorp announces partnership for colorectal cancer trials
The trial will assess if direct outreach by healthcare providers increases cascade genetic testing among first-degree ...
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its fourth-quarter 2025 results on Feb. 17, before the market opens. The renowned laboratory service provider reported adjusted earnings of $4 ...
BURLINGTON, N.C. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, and ConcertAI, LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) ...
Innovative GFAP blood biomarker test expands Labcorp's portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April 15, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results